We observed that treatment of SSc fibroblasts with G150 strongly reduced the cGAS-induced enzymatic (2′3′ cGAMP) activity and the production of IFN-β in SSc fibroblasts (Fig. 8c, d). The gene discussed is IFNB1; the disease is systemic sclerosis.